Filing summary
Important entity mismatch: The supplied filing is Concord Acquisition Corp III’s Form 10-K, not GCT Semiconductor Holding, Inc.’s. It reports the SPAC’s fiscal year ended December 31, 2023; it does not provide GCT’s operating results. It also does not present standalone fourth-quarter financial results.
Business context and reporting period
Concord III was a special purpose acquisition company (SPAC) with no operating business or operating revenue. Its principal activity was pursuing a merger with GCT Semiconductor, Inc. The proposed transaction would make GCT a wholly owned subsidiary, subject to closing conditions. Concord’s stockholders approved the transaction at a special meeting on February 27, 2024, after the fiscal year-end.
Financial performance and position
| Metric | FY 2023 | FY 2022 |
|---|---|---|
| Revenue | No operating revenue | No operating revenue |
| Net income (loss) | $(2.0) million | $24.3 million |
| Operating costs, net | $4.9 million | $1.2 million |
| Trust-account investment income | $6.8 million | $5.1 million |
| Net cash used in operating activities | $2.7 million | $1.5 million |
- FY 2023’s loss included a $2.9 million adverse change in fair value of warrant liabilities and sponsor loans, and $1.4 million in income-tax expense. FY 2022’s profit was substantially affected by a $21.3 million favorable fair-value change in those instruments; these non-cash valuation changes make the year-over-year earnings comparison less indicative of operating performance.
- At December 31, 2023, total assets were $42.7 million, including $42.4 million in the trust account and $16,371 in cash outside the trust. Current liabilities were $7.3 million; total liabilities were $14.8 million. Shares subject to possible redemption were recorded as $42.4 million of temporary equity.
- Cash flows included $318.4 million withdrawn from the trust account for redemptions and taxes, largely offset by $318.4 million of redemption payments. Operating cash use was $2.7 million.
- Debt-related items included a $35,000 sponsor promissory note at year-end. The $6.9 million sponsor loans had no recorded fair value at year-end following an agreement to forgive them upon completion of the proposed combination; forgiveness remained conditional on closing.
Margins are not meaningful because Concord had no operating revenue. The filing does not provide GCT revenue, profitability, cash flow, debt, or liquidity metrics.
Material changes and transaction terms
- In May 2023, holders redeemed 30.46 million shares for approximately $317.4 million, leaving about $42.0 million in the trust account. In November, a further 98,573 shares were redeemed for about $1.1 million; approximately $42.2 million remained in trust after those redemptions.
- The proposed GCT transaction uses a stated company value of $350 million, adjusted for GCT debt, cash and certain warrant proceeds; the equity consideration is calculated at $10 per share. The agreement also provides for up to 20 million contingent earnout shares at specified share-price thresholds.
- PIPE investors committed approximately $29.9 million for 4,484,854 shares at $6.67 per share, conditional on the transaction closing. Sponsor support terms include forgiveness of the sponsor loans and possible forfeiture or transfer of sponsor shares and warrants.
- One underwriter waived a $6.99 million deferred commission; remaining deferred commissions were $5.08 million, payable upon a business combination. Concord also accrued a $2.5 million capital-markets advisory fee and reported $3.18 million of excise tax payable related to redemptions.
Outlook, risks, and unusual items
- Concord’s deadline to complete a business combination was August 8, 2024. Failure to complete it or obtain an extension would require liquidation; public warrants would expire worthless. Management and the auditor cited substantial doubt about Concord’s ability to continue as a going concern, including because it had only $16,371 of working cash outside the trust at year-end.
- The NYSE notified Concord in January 2024 that it had fewer than the required 300 public stockholders. Concord submitted a compliance plan on February 28, 2024; continued listing was not assured.
- Management concluded disclosure controls and internal control over financial reporting were ineffective at December 31, 2023 because of a material weakness in accounting for complex financial instruments. Remediation was underway but not assured; the auditor did not attest to internal controls.
- Key risks include transaction completion and redemption levels, limited working capital and reliance on potential financing, dilution, warrant valuation volatility, third-party claims against trust funds, potential delisting, and conflicts of interest. The filing also cites macroeconomic and geopolitical uncertainty.
Most important facts for investors to verify
- Whether the intended subject is Concord III or GCT Semiconductor; this filing does not summarize GCT’s operating financials.
- Whether the transaction closed, the final redemption count and cash delivered at closing, and any financing or transaction-term changes after the filing.
- GCT’s audited financial statements and current liquidity, debt, customer concentration, and revenue outlook in the transaction registration materials.
- The NYSE’s decision on Concord’s compliance plan and the status of the internal-control material weakness.
- The final treatment of deferred fees, the capital-markets advisory fee, excise tax, sponsor loans, and potential dilution from earnouts, PIPE shares, founder shares, and warrants.